Status:

ENROLLING_BY_INVITATION

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Lead Sponsor:

Mayo Clinic

Conditions:

Infections Joint Prosthetic

Overweight or Obesity

Eligibility:

All Genders

18-99 years

Phase:

PHASE4

Brief Summary

To determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee art...

Detailed Description

The purpose of this research study is to investigate whether a 7-day course of an oral, prophylactic antibiotic following elective, primary total hip and knee arthroplasty effectively decreases the ri...

Eligibility Criteria

Inclusion

  • Patient is a candidate for elective, primary total hip arthroplasties (THA) or total knee arthroplasties (TKA).
  • Patient is considered high-risk for developing Periprosthetic joint infections (PJI) based on having at least one of the following criteria:
  • Body mass index (BMI) \> 35 kg/m\^2;
  • Diagnosis of diabetes mellitus;
  • Active tobacco smoker;
  • Chronic kidney disease;
  • Autoimmune disease;
  • Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-sensitive Staphylococcus aureus (MSSA).

Exclusion

  • Inability to consume oral antibiotics.
  • Allergy to antibiotic alternatives in the protocol.
  • History of clostridium difficile colitis.
  • Revision hip or knee arthroplasty procedure.
  • Non-elective surgery.
  • Hemiarthroplasty.
  • Unicompartmental knee arthroplasty.
  • Simultaneous bilateral THA or TKA.
  • Will have subsequent THA or TKA within 12 weeks of the index study procedure.
  • Pregnant.

Key Trial Info

Start Date :

June 11 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

4618 Patients enrolled

Trial Details

Trial ID

NCT04297592

Start Date

June 11 2020

End Date

June 1 2026

Last Update

July 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Iowa Hospitals & Clinics

Iowa City, Iowa, United States, 52242

2

Mayo Clinic

Rochester, Minnesota, United States, 55902